60 DEGREES PHARMACEUTICALS, INC. - Annual Financials - Equity (SEC)

Updated on January 3, 2026.

Related Topics: SEC Topic List.

Data Source: SEC.

See details in table below.

You can see similar for other companies.

60 DEGREES PHARMACEUTICALS, INC. - Annual Equity (In Thousands of USD, Except Per Share Amounts)

Breakdown	2024-12-31	2023-12-31	2022-12-31
Balance	34860.59	27457.373	-28815.148
Balance (in Shares)	76.48	78.803	0
Issuance of common stock and warrants, net of underwriting discounts and offering costs paid at closing and deferred offering costs (Note 6)	0
Issuance of common stock and warrants, net of underwriting discounts and offering costs paid at closing and deferred offering costs (Note 6) (in Shares)	2.537
Issuance of common stock upon exercise of Pre-Funded Warrants	10.963
Issuance of common stock upon exercise of Pre-Funded Warrants (in Shares)	211.163
Issuance of shares for RSUs	0
Issuance of shares for RSUs (in Shares)	4.27
Voluntary return of shares issued to vendor for services	0
Voluntary return of shares issued to vendor for services (in Shares)	2
Voluntary conversion of Series A Preferred Stock into common stock	0	0
Voluntary conversion of Series A Preferred Stock into common stock (in Shares)	-2.323	0.76
Share-based compensation under 2022 Equity Incentive Plan		528.926
Share-based compensation under 2022 Equity Incentive Plan (in Shares)		0.668
Contribution from noncontrolling interest		548.38
Deemed capital contribution for related party compensation expense (Note 11)		163.228
Issuance of common stock pursuant to ATM Offering, net of offering costs paid at closing and deferred offering costs of $264,774	0.014
Issuance of common stock pursuant to ATM Offering, net of offering costs paid at closing and deferred offering costs of $264,774 (in Shares)	135.568
Issuance of warrants in Private Placement, net of offering costs paid at closing and deferred offering costs of $582,600	3414.502
Issuance of common stock for fractional shares pursuant to Reverse Stock Split rounding adjustment	-0.002
Issuance of common stock for fractional shares pursuant to Reverse Stock Split rounding adjustment (in Shares)	18.71
Cancellation of common stock		0
Cancellation of common stock (in Shares)		24.186
Share-based compensation to vendors for services	26.325	0
Share-based compensation to vendors for services (in Shares)		24.717
Conversion of debt into common stock upon initial public offering		0
Conversion of debt into common stock upon initial public offering (in Shares)		28.46
Conversion of debt into Series A Preferred Stock upon initial public offering		0
Conversion of debt into Series A Preferred Stock upon initial public offering (in Shares)		80.965
Reclassification of liability-classified warrants to equity-classified		0
Issuance of common stock pursuant to IPO, net of underwriting discounts, commissions, and deferred offering costs of $1,266,740		0
Issuance of common stock pursuant to IPO, net of underwriting discounts, commissions, and deferred offering costs of $1,266,740 (in Shares)	6.26	23.585
Issuance of common stock upon exercise of warrants		1131.771
Issuance of common stock upon exercise of warrants (in Shares)		0	0
Share-based compensation expense	0	119.246
Net foreign translation gain (loss)	-0.09	61.853
Net income (loss)	0	-48.098
Balance	34860.59	27457.373	-28815.148
Balance (in Shares)	76.48	78.803	0
Issuance of common stock net of offering costs paid	264.774
Issuance of warrants in Private Placement, net of offering costs paid	582.6
Issuance of common stock pursuant to IPO, net of underwriting discounts		1266.74